| scholarly article | Q13442814 |
| P50 | author | Cesare Montecucco | Q504278 |
| Marco Pirazzini | Q47151643 | ||
| Giulia Zanetti | Q57080835 | ||
| Aram Megighian | Q57318853 | ||
| Elisa Duregotti | Q85783502 | ||
| P2093 | author name string | Michela Rigoni | |
| Michele Scorzeto | |||
| P2860 | cites work | Botulinal neurotoxins: revival of an old killer | Q23832313 |
| alpha-Latrotoxin and its receptors | Q24641963 | ||
| Molecular machines governing exocytosis of synaptic vesicles | Q26849286 | ||
| Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution | Q27765619 | ||
| alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins | Q28214351 | ||
| ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease | Q28392297 | ||
| The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction | Q31036598 | ||
| Neurotoxins affecting neuroexocytosis | Q33881286 | ||
| 39 Tetanus and botulism neurotoxins: Isolation and assay | Q34305416 | ||
| Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures | Q34474542 | ||
| Presynaptic enzymatic neurotoxins. | Q34542589 | ||
| Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cells | Q35062594 | ||
| Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. | Q35068975 | ||
| Common krait (Bungarus caeruleus) bite in Anuradhapura, Sri Lanka: a prospective clinical study, 1996-98. | Q35514143 | ||
| Nerve terminal damage by beta-bungarotoxin: its clinical significance | Q35745331 | ||
| SNARE complexes and neuroexocytosis: how many, how close? | Q36151465 | ||
| VAMP/synaptobrevin isoforms 1 and 2 are widely and differentially expressed in nonneuronal tissues | Q36236418 | ||
| Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A2. | Q36955570 | ||
| Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion | Q37407302 | ||
| Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction | Q37535345 | ||
| Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review | Q37695920 | ||
| Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering | Q37954285 | ||
| Clinical applications of botulinum toxin | Q38024438 | ||
| Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins | Q38048397 | ||
| Clinical utility of different botulinum neurotoxin preparations | Q38078628 | ||
| The life history of a botulinum toxin molecule | Q38091815 | ||
| The blockade of the neurotransmitter release apparatus by botulinum neurotoxins | Q38113138 | ||
| Venomous snake bites, scorpions, and spiders | Q38173534 | ||
| Botulinum neurotoxins: genetic, structural and mechanistic insights. | Q38224215 | ||
| Alpha-latrotoxin rescues SNAP-25 from BoNT/A-mediated proteolysis in embryonic stem cell-derived neurons. | Q38843198 | ||
| Growth of clostridia and preparation of their neurotoxins. | Q40935923 | ||
| Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions | Q41107515 | ||
| Evidence for a radial SNARE super-complex mediating neurotransmitter release at the Drosophila neuromuscular junction. | Q43536809 | ||
| The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis | Q43576030 | ||
| Neuromuscular effects of Papuan Taipan snake venom | Q46173367 | ||
| The effects in the mouse of nerve crush and regneration on the innervation of skeletal muscles paralysed by Clostridium botulinum toxin | Q47758700 | ||
| Different types of botulinum toxin in humans | Q47935598 | ||
| Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. | Q50753722 | ||
| Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. | Q50755840 | ||
| Persistence of botulinum toxin in patients' serum: Alaska, 1959-2007. | Q51832159 | ||
| The neuromuscular junction of the mouse after black widow spider venom | Q52506019 | ||
| Calpains participate in nerve terminal degeneration induced by spider and snake presynaptic neurotoxins. | Q53127930 | ||
| Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins. | Q54193253 | ||
| Axonal transport and distribution of synaptobrevin I and II in the rat peripheral nervous system | Q57979046 | ||
| Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation | Q58120767 | ||
| Electrophysiological findings in patients envenomed following the bite of a Papuan taipan (Oxyuranus scutellatus canni) | Q58214382 | ||
| Calcium Influx and Mitochondrial Alterations at Synapses Exposed to Snake Neurotoxins or Their Phospholipid Hydrolysis Products | Q63408246 | ||
| A comparison of the safety margins of botulinum neurotoxin serotypes A, B, and F in mice. | Q64930611 | ||
| Increased survival time in botulinum toxin poisoning by treatment with a venom gland extract from the black widow spider | Q66838782 | ||
| Survival after snake-bite with prolonged neurotoxic envenomation | Q70532480 | ||
| The effects of black widow spider venom on the innervation of muscles paralysed by botulinum toxin | Q72946672 | ||
| Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia | Q73114329 | ||
| Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety | Q74333038 | ||
| Pre-existing pathways promote precise projection patterns | Q74598597 | ||
| RESTORATION OF FUNCTION IN BOTULINUM PARALYSIS BY EXPERIMENTAL NERVE REGENERATION | Q76930374 | ||
| Persistence of botulinum neurotoxin action in cultured spinal cord cells | Q78144026 | ||
| Long-distance retrograde effects of botulinum neurotoxin A | Q81006671 | ||
| Botulism | Q81651281 | ||
| Calcium overload in nerve terminals of cultured neurons intoxicated by alpha-latrotoxin and snake PLA2 neurotoxins | Q83601589 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuromuscular junction | Q776995 |
| P304 | page(s) | 5322-5336 | |
| P577 | publication date | 2015-12-08 | |
| P1433 | published in | Toxins | Q15724569 |
| P1476 | title | Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction | |
| P478 | volume | 7 |
| Q58572728 | A Metalloprotease Homolog Venom Protein From a Parasitoid Wasp Suppresses the Toll Pathway in Host Hemocytes |
| Q64094807 | A Novel Optical Tissue Clearing Protocol for Mouse Skeletal Muscle to Visualize Endplates in Their Tissue Context |
| Q40085919 | Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission. |
| Q40184284 | Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication |
| Q47151130 | Neurophysiological Measures of Efficacy and Safety for Botulinum Toxin Injection in Facial and Bulbar Muscles: Special Considerations |
| Q52626788 | The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes. |
| Q55516083 | Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms. |
| Q89955461 | WITHDRAWN: Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus |
Search more.